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Abstract
Background: Registered data can provide valuable information regarding blindness. The purpose of this study was
to evaluate the main causes and 3-year incidence of registered blindness in Jing-An district in Shanghai, China.
Methods: Data from the blindness registry (age, gender and cause of visual disability) were collected and analyzed.
The prevalence of blindness for 2003, 2007, 2009 and the 3-year incidence of blindness were calculated.
Results: The reported blindness increased significantly from 113.7 per 100,000 in 2003 to 145.8 per 100,000 in 2006
to 165.9 per 100,000 in 2009 (P < 0.05, P < 0.05, respectively). Age significantly affects prevalence; the odd ratios
(OR) were 2.57 in the 30 y - 49 y range (P < 0.001), 7.27 in the 50 y - 69 y range (P < 0.001) and 21.2 in the ≥ 70 y
(P < 0.001). The 3-year incidence increased from 32.3 per 100,000 in 2001-2003 to 34.2 per 100,000 in 2004-2006 to
40.8 per 100,000 in 2007-2009. The causes of new blindness registered in 2001-2009 were myopic macular
degeneration (19.4%), followed by glaucoma (17.7%), age-related macular degeneration (11.8%), optical nerve
atrophy (9.4%), retinitis pigmentosa (8.6%), diabetic retinopathy (7.8%) and corneal opacity (5.8%).
Conclusions: The 3-year incidence and prevalence of registered blindness increased in the past 9 years. The
leading causes of new blindness were myopic macular degeneration, glaucoma and age-related macular
degeneration. The pattern of causes has changed little in the past 9 years and is different from other locations in
China. The pattern is similar to that of Taiwan, Hongkong, and Western countries.
Background
The World Health Organization (WHO) encourages all
countries to monitor the magnitude and causes of visual
impairment in order to scrutinize and eliminate avoid-
able blindness [1]. Registered data can provide valuable
information regarding blindness. Blindness registries
mainly exist in developed countries and are held by
state or partially state funded organizations that provide
some kind of assistance to the visually disabled[2].
China is a developing country and cannot provide funds
to establish a nationwide networked blindness registry.
Also varied socioeconomic conditions affect the devel-
opment of this project in different regions of China.
Shanghai is the largest metropolis in China and its
GDP per capita reached $10,529 USD in 2008[3]. Jing-
An district is among the nine downtown districts of
Shanghai, where a public welfare system is most
developed. Jing-An district established a blindness regis-
try in 1992, which is held by the local Disabled Person’s
Federation (DPF), which is funded by the local govern-
ment. Although registration is entirely voluntary, it con-
fers significant practical and monetary benefits. We
analyzed the data from the Jing-An district DPF with
specific objectives including: (1) to identify the causes of
registered blindness and to calculate the gender and
age-specific prevalence of blindness; (2) to calculate the
3-year incidence of registered blindness in the most
recent 9 years; and (3) to suggest priorities for research
and intervention strategies for blindness.
Methods
This study is based on the blindness data of the Jing-An
district DPF. Age, gender and cause of visual disability
data were collected and analyzed. The prevalence at the
end of years 2003, 2007, 2009 and the 3-year incidence
of blindness was calculated. The study was performed in
accordance with the Declaration of Helsinki for research
involving human subjects. The study met all standards
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T h ec r i t e r i af o rr e g i s t e r i n gb l i n d n e s si nC h i n aa r ei n
accordance with the WHO categories of visual impair-
ment, and the category of interest for our study was
that the visual impairment was irreversible [4]. Blindness
was defined as a best spectacle corrected visual acuity
(BSCVA) of less than 3/60 in the better eye, or a corre-
sponding visual field loss to less than 10 degrees in the
better eye with best possible correction.
All registered blindness cases need to undergo an
assessment of visual impairment. The assessment system
has been in place in Jing-An district central hospital from
1992 to the present. In the first 9 years, the causes of
blindness were not recorded. From 2001, a comprehen-
sive ocular examination was performed on every appli-
cant including uncorrected visual acuity (UCVA),
refraction, BSCVA, ophthalmoscope examination and
retinal photography. Visual field tests were performed by
a kinetic arctic perimeter (YZ22, 66 Vision Tech. Co.,
Ltd, China) when visual disability was due to glaucoma,
retinitis pigmentosa (RP) and other optic nerve diseases.
The causes of blindness were classified according to the
International Classification of Diseases, 10th edition [5].
Myopic macular degeneration (MMD) was considered
only in subjects with a refractive error exceeding -6.0 diop-
ters in either eye with one or more of the following
ophthalmologic findings: tessellated fundus with yellowish
white diffuse or grayish white patchy chorioretinal atro-
phy, macular hemorrhage or posterior staphyloma [6].
Age-related macular degeneration (AMD) was defined
according to the Wisconsin age-related maculopathy grad-
ing system [7]. Early AMD was defined by the presence of
either soft indistinct drusen or the presence of any type of
drusen associated with retinal pigment epithelium depig-
mentation or increased retinal pigment. Late AMD was
defined by the appearance of either exudative macular
degeneration or pure geographic atrophy. Glaucoma was
defined according to the International Society for Geogra-
phical and Epidemiological Ophthalmology classification
[8]. Diagnosis of RP was based on night blindness, pro-
gressive loss of peripheral visual field, and decreased visual
acuity with age, as well as on typical signs observed under
fundus examination. The diagnosis of diabetic retinopathy,
corneal opacity, and other diseases as causes of blindness
followed the ophthalmology practice guidelines edited by
the China Academy of Ophthalmology.
Using best judgement, the ophthalmologist attempted
to identify the disorder causing the greatest limitation of
vision as the cause of blindness. The causes of blindness
in both eyes were recorded. When two causes appeared
to have an equal contribution to visual impairment for
one eye, the primary cause was assigned as the cause of
blindness. If cataract was regarded as the main cause of
blindness, the patient was referred for surgery and reas-
sessed at least 2 months postoperatively if visual func-
tion restored unsatisfactorily.
Statistical analysis was performed using SPSS software
version 13 (SPSS, Inc., Chicago, IL). The incidence of
blindness caused by some diseases is low and varied in
different years in a defined area, so we calculated the 3-
year incidence of registered blindness per 100,000 in
order to reduce the deviation of incidence in different
year. And the prevalence of registered blindness per
100,000 were also calculated. Age was grouped as 1 y -
29 y, 30 y - 49 y, 50 y - 69 y and 70 y or older. Binary
logistic regression was used to analyze the factors
related to the occurrence of registered blindness. Odds
ratios and 95% confidence intervals were determined to
describe the influence of age and gender on the preva-
lence of visual impairment. A Chi-square test was used
to analyze the difference between genders. P < 0.05 was
considered as statistically significant.
Results
Prevalence and causes
The number of people in the blindness registry
increased from 378 in 2003 to 458 in 2006 to 514 in
2009. The reported blindness also increased significantly
from 114.7 per 100, 000 in 2003 to 145.8 per 100,000 in
2006 to 165.9 per 100,000 in 2009 (P < 0.05, P < 0.05,
respectively). The age-specific prevalence and gender-
specific prevalence for 2009 are summarized in Table 1.
Table 1 Prevalence of blindness in Jing-An district,
Shanghai, China in 2009
Age(yrs) population blind Prevalence 95%CI
lower Upper
FEMALE
1-29 43152 15 34.8 17.2 52.3
30-49 42425 22 51.9 30.2 73.5
50-69 47173 109 231.1 187.7 274.4
70 or 70+ 25822 112 433.7 353.6 513.9
Total 158572 258 162.7 142.9 182.5
MALE
1-29 44153 7 15.9 4.1 27.6
30-49 40752 39 95.7 65.7 125.7
50-69 47383 87 183.6 145.1 222.2
70 or 70+ 18893 123 651 536.3 765.7
Total 151181 256 169.3 148.6 190.1
TT
1-29 87305 22 25.2 14.7 35.7
30-49 83177 61 73.3 54.9 91.7
50-69 94556 196 207.3 178.3 236.3
70 or 70+ 44715 235 525.6 458.5 592.6
Total 309753 514 165.9 151.6 180.3
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Page 2 of 6The association of sex and age with blindness was calcu-
lated with a logistic regression model, as shown in
Table 2. Gender was not a significant factor, but age sig-
nificantly affected the prevalence. The odd ratios (OR)
were 2.57 in the 30 y - 49 y group (P < 0.001), 7.27 in
the 50 y - 69 y group (P < 0.001), and 21.2 in the 70 y
or older group (P < 0.001).
The leading causes of blindness that were registered in
2001-2009 are summarized in Table 3. The causes of
blindness were MMD (19.4%), followed by glaucoma
(17.7%), AMD (11.8%), optical nerve atrophy (9.4%), RP
(8.6%), diabetic retinopathy (7.8%) and corneal opacity
(5.8%).
3-year incidence
The 3-year incidence of registered blindness increased
from 32.3 (range 26.0-38.6) per 100,000 in 2001-2003 to
34.2 (range 20.7-40.7) per 100,000 in 2004-2006 to 40.8
(range 40.1-55.5) per 100,000 in 2007-2009 (Table 4). In
the blindness registry, retinal detachment was the third
cause in 2001-2003, but became the eighth in 2004-2006
and the seventh cause in 2007-2009. Optic nerve atro-
phy was the fourth cause of blindness in 2001-2003, and
became the seventh cause in 2004-2006 and the eighth
cause in 2007-2009. However, AMD was the fifth cause
in 2001-2003, the third in 2004-2006, and the third in
2007-2009.
Age and new blindness
The ages of the registered cases of new blindness is
summarized in Table 5. The average registered age was
64.19 ± 15.86 y. The average registered age increased
from 60.1 ± 17.3 y in 2001-2003 to 65.4 ± 15.2 y in
2004-2006 to 66.1 ± 14.8 y in 2007-2009 (P < 0.05, P <
0.05, respectively). The main reason for the increased
age of new blindness was that there was an increase in
the age of the registered blind due to MMD, optic nerve
atrophy, corneal opacity and AMD.
Discussion
To our knowledge, this is the first report on registered
blindness in China. Because of the varied socioeconomic
levels in China, and the independence of registries in dif-
ferent regions, it is impossible to obtain a complete
national dataset, as well as a complete dataset for Shang-
hai. We therefore analyzed limited data based on the
blindness registry in Jing-An district, Shanghai, China.
The number of people in the blindness registry in
Jing-An district has increased by 36% since 2003 and by
13% since 2007. In contrast, the population of the dis-
trict remained stable. The increase in the prevalence
and incidence of blindness during 2001-2009 likely
represents increased registration rather than increasing
levels of disease, considering the short time period
involved. Higher life expectancy in the general popula-
tion in Shanghai may have contributed as well; accord-
ing to an official publication of the Shanghai Bureau of
Statistics, life expectancy in 2001 was 79.7 y and 81.3 y
in 2009[3].
Table 2 Association of registered blindness with gender
and age in Jing-an district in 2009
OR 95%CI P
lower Upper
Sex male 1
female 0.87 0.73 1.04 0.12
age 1-29 1
30-49 2.57 2.13 3.11 <0.001
50-69 7.27 5.48 9.63 <0.001
70 or 70+ 21.20 13.69 32.84 <0.001
CI: confidence interval
OR: odds ratio (binary logistic regression)
Table 3 Causes of new registered blindness in Jing-An district, Shanghai, China in 2001-2009
2001-2003 2004-2006 2007-2009
Causes cases eyes % order Incidence 1/
100000
cases eyes % order Incidence 1/
100000
case eyes % order Incidence 1/
100000
MMD 15 29 14.5 2 4.8(2.4,7.3) 17 32 15.1 1 5.5(2.9,8.1) 39 74 26.1 1 12.6(8.6,16.5)
Glaucoma 19 38 19.0 1 6.1(3.4,8.9) 16 32 15.1 1 5.2(2.6,7.7) 28 53 18.7 2 9.0(5.7,12.4)
AMD 13 20 10.0 5 4.2(1.9,6.5) 16 29 13.7 3 5.2(2.6,7.7) 19 33 11.6 3 6.1(3.4,8.9)
RP 6 11 5.5 7 1.9(0.4,3.5) 13 26 12.3 4 4.2(1.9,6.5) 12 23 8.1 4 3.9(1.7,6.1)
Diabetic 8 16 8.0 6 2.6(0.8,4.4) 8 16 7.6 6 2.6(0.8,4.4) 11 22 7.8 5 3.6(1.5,5.6)
CO 3 4 2.0 9 1.0(0,2.1) 10 15 7.1 7 3.2(1.2,5.2) 16 21 7.4 6 5.2(2.6,7.7)
RD 15 27 13.5 3 4.8(2.4,7.3) 5 8 3.8 8 1.6(0.2,3.0) 10 16 5.6 7 3.2(1.2,5.2)
ONA 13 26 13.0 4 4.2(1.9,6.6) 14 25 11.8 5 4.5(2.2,6.9) 7 14 4.9 8 2.3(0.6,3.9)
UVITIS 3 6 3.0 8 1.0(0,2.1) 4 7 3.3 9 1.3(0,2.6) 6 10 3.5 9 1.9(0.4,3.5)
OTHERS 17 23 11.5 5.5(2.9.8.1) 12 22 10.4 3.9(1.7,6.1) 16 18 6.3 5.2(2.6,7.7)
Total 100 200 100.0 32.3(25.9,38.6) 106 212 100.0 34.2(27.7,40.7) 142 284 100.0 45.8(38.3,53.4)
MMD: myopic macular degeneration; AMD: age-related macular degeneration; ONA: optic nerve atrophy; RP: retinitis pigmentosa; CO: corneal opacity; RD: retinal
detachment.
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Page 3 of 6Currently, the overall prevalence of blindness is 0.17%
for the total population, 0.21% for ages 50 y - 69 y, and
0.53% for ages 70 y or older. The prevalence in this
study is lower than that reported in most studies based
on a sample of the population in urban China (Table 6)
[6,9-19]. This is possibly due to inclusion of blindness
due to cataracts in the studies. A recent study showed
the prevalence of blindness was 0.61% for ages 70 y or
older in Shanghai and 29.4% was due to cataract [17],
which is a prevalence rate closer to our results. Another
study in Henan province showed that the prevalence of
blindness in urban areas was only 0.09% [18]. To our
knowledge, there are no data available on the incidence
of blindness in China to compare with this study. It is
difficult to compare the incidence and prevalence of
blindness with other countries because of different defi-
nitions of blindness and difference age distributions.
T h ep r e v a l e n c eo fr e g i s t e r e db l i n d n e s sw a s0 . 1 7 %-
0.22% in Ireland (blindness was defined as BSCVA in
the better eye of less than 6/60)
2 and 0.26% - 0.32% in
Israel (using WHO criteria) [20]. The incidence of regis-
tered blindness was 0.036% - 0.029% in Israel (using
WHO criteria), 0.02% in Ireland (using US criteria) and
0.012% in southern Germany (blindness was defined as
BSCVA in the better eye of less than 1/50) [20-22]. In
our study, blindness was defined by WHO criteria and
cataract was extirpated as the cause of registered
blindness. Young babies were also enrolled in this study,
which would decrease the prevalence and incidence of
blindness.
The leading causes of blindness in the present study
were MMD (22.6%), glaucoma (18.7%), AMD (11.6%)
and RP (8.1%). Some studies showed that corneal opa-
city was also a major cause of blindness in China
(shown in Table 5) [9,12-18]. In the present study cor-
neal opacity was the eighth cause of blindness.
Although the number of cases of corneal opacity
increased, along with an increase in the registered age
from 43.0 ± 33.9 y in 2001-2003 to 72.8 ± 11.3 y in
2007-2009, visual acuity must have been lost in an ear-
lier stage. The reason for this is that infectious keratitis
and trachoma have been well controlled in Shanghai. A
recent study showed that glaucoma was the eighth
cause of blindness and accounted for 4.1% of blindness
in Shanghai, whereas it was the second cause at 18.7%
in the present study [17]. However, no visual field
examinations were performed in their study. AMD has
increased dramatically as a cause of blindness. It was
the fifth cause in 2001-2003, while it became the third
cause in 2007-2008. The pattern of causes of blindness
was similar to that in Taiwan, Hongkong, and Western
countries [6,11,20-22]. Glaucoma and AMD have also
become the leading causes of blindness in the Jing-An
district of Shanghai.
Table 4 Prevalence and 3-years-incidences of blindness in Jing-An district, Shanghai, China
2001-2003 2004-2006 2007-2009
Population(10,000) 33.24 30.96 30.97
Blind 378 458 514
Prevalence rate (95%CI)(1/100,1000) 113.7(102.3-125.2) 147.9(134.4-161.5) 165.9(151.6-180.3)
New blind 100 106 142
3-year-incidence (95%CI) (1/100,1000) 32.3(26.0-38.6) 34.22(27.7-40.7) 47.78(40.1-55.5)
Table 5 Registered age of new blindness in Jing-An district, Shanghai, China
2001-2009 2001-2003 2004-2006 2007-2009
Mean ± 1SD Mean ± 1SD Mean ± 1SD Mean ± 1SD
Glaucoma 67.30 ± 14.61 65.89 ± 14.01 67.94 ± 16.23 67.89 ± 14.52
Diabetic 63.00 ± 13.79 63.38 ± 13.73 58.00 ± 14.14 63.64 ± 14.92
MMD 61.32 ± 12.22 54.60 ± 16.61 61.12 ± 11.36 64.00 ± 9.68*
RP 57.29 ± 13.83 58.00 ± 13.28 59.15 ± 10.16 54.92 ± 17.83
AMD 75.31 ± 9.42 71.00 ± 8.98 77.70 ± 9.28* 75.74 ± 9.31
ONA 59.25 ± 17.43 53.23 ± 19.74 66.69 ± 12.24* 53.43 ± 18.82
CO 67.52 ± 16.55 43.00 ± 33.87 66.40 ± 11.50* 72.81 ± 11.33*
RD 61.97 ± 13.78 57.47 ± 15.58 68.80 ± 8.81 65.30 ± 11.28
UVITIS 62.77 ± 14.93 60.33 ± 14.15 59.25 ± 11.95 66.33 ± 18.45
OTHERS 59.93 ± 23.18 58.44 ± 21.51 54.18 ± 27.03 65.73 ± 22.16
Total 64.19 ± 15.86 60.10 ± 17.29 65.43 ± 15.24* 66.12 ± 14.82*
MMD: myopic macular degeneration; AMD: age-related macular degeneration ONA: optic nerve atrophy; RP: retinitis pigmentosa; CO: corneal opacity; RD: retinal
detachment.
*:P < 0.05 compared to in 2001-2003
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Page 4 of 6The analysis shows the importance of glaucoma as the
leading cause of blindness in China today. Most patients
with glaucoma can maintain sufficient visual acuity if
effective treatment is given at an early stage, especially
for primary angle-closure glaucoma (PACG), which is
major category of glaucoma in China. The study showed
that 92.86% of blindness due to glaucoma occurred at
51 y or older. We therefore suggest that local health
bureaus should conduct glaucoma screening for those
aged 51 y or older to diagnose glaucoma at an early
stage.
AMD and MMD are the chief causes leading to blind-
ness. Unfortunately, for most people with AMD, vision
loss can neither be prevented nor adequately reversed.
There is clearly a need for further research on the
causes and risk factors of AMD. Persons with MMD
w i l la l s ob e n e f i tf r o mt h er e s e a r c h .C o n t r o l l i n gt h e
development of high myopia is impending. Research on
the mechanisms of myopia progression is necessary to
decrease the vision impairment burden of students.
This study is based on registered data for a defined
geographic area. We acknowledge there are some limita-
tions in our study. We had to rely on the limited
information from the CDPF, and the causes of blindness
registered before 2001 were not recorded. The increase
in the prevalence and incidence of blindness likely
represents increased registration rather than increasing
levels of disease. In this study, the cause of blindness
was recorded for each eye, which would increase the
proportion of disorders with a bilateral tendency such as
AMD, MMD and glaucoma as the cause of blindness. It
would be better to record the causes by case. The effi-
cacy of the registration system is not certain. Previous
studies in other countries found that only 45% - 60% of
eligible patients were registered [23]. It is therefore
necessary to make a dedicated effort to evaluate the effi-
cacy of the registry system in China.
Conclusions
The 3-year incidence and reported blind increased in
the past 9 years. The leading causes of new cases of
blindness that were registered were MMD, glaucoma
and AMD. The pattern of causes has changed little in
the past 9 years, is different from other locations in
China, and is similar to patterns in Taiwan, Hongkong
and Western countries.
Table 6 Prevalence of blindness and its causes reported from population based studies in china
Country Age(yrs) Prevalence Main causes
Beijing, China
(Xu L et al.2006)
> = 40 0.3% Cataract(38.5%); Cornea opacity (15.4%);Myopic macular degeneration(7.7%); Glaucoma(7.7%)
Handan china
(Liang YB et al. 2008)
> = 30 0.5% Cataract (36.6%);Myopic macular degeneration (19.5%)
Glaucoma(7.3%);Cornea opacity(7.3%)
Taiwan, China
(Hsu WM, et al. 2004)
> = 65 0.59% Cataract (41.7%);Myopic macular degeneration (12.5%)
AMD(10.4%)
Hongkong, China
(Michon JJ, et al. 2002)
> = 60 1.8% Cataract (51.7%);Macular degeneration (27.1%)
Glaucoma(7.1%)
Hebei, China
(Song XJ.1992)
0.19%
in urban
areas
Cataract(32.3%);trachoma complications(13.4%)
corneal disease(13.06%);glaucoma(9.97%)
Shanxi, China
(Zhang JX.1990)
0.18%
in cities
Cataract (29.7%)
Shangdong, china
(Yu XM.1992)
0.34% Cataract, corneal diseases and glaucoma in urban areas
China
(Zhang SY.1992)
0.43% Cataract(41.06%);Corneal disease(15,38%)
Trachoma (10.4%);Glaucoma (8.8%)
Chongqing, china
(Liu S, et al. 2007)
>50 1.8% Cataract (17.9%);Retinal diseases (20.7%); refraction error(15.4%);
cornea disease (11.6%); glaucoma (13.4%)
Shanghai
(Huang XB, et al. 2009)
0.95%
in 60-79 yrs
0.68%
in 70-79 yrs
0.40%yrs
in 80 yrs or
older
Macular degeneration(28.57%);Cataract(27.27%); Corneal opacity (6.49%);
Retinal detachment (5.84%); Optical nerve atrophy (5.19%); Retinitis pigmentosa (5.19%)
Henan
(Li Y et al.2009)
0.09%
in urban
no noted
Hubei
(Chen W et al. 2009)
0.33%
in urban
Cataract (54.55%);Glaucoma(10.22%); Congenital abnormal (8.41%);Corneal disease(7.48%);
Retinal and choroidal disease (6.54%)
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